Authors

• Jung‐Woo Son (ORCID: https://orcid.org/0000-0002-1790-3228)
• Byung‐Su Yoo (ORCID: https://orcid.org/0000-0002-3395-4279)
• Dong‐Hyuk Cho (ORCID: https://orcid.org/0000-0001-8480-9082)
• Jong‐Chan Youn (ORCID: https://orcid.org/0000-0003-0998-503X)
• Jimi Choi (ORCID: https://orcid.org/0000-0003-2834-2718)
• Chan Joo Lee (ORCID: https://orcid.org/0000-0002-8756-409X)
• Mi‐Na Kim (ORCID: https://orcid.org/0000-0001-6589-5122)

Institutions

• Yonsei University (KR)
• Korea University (KR)
• Severance Hospital (KR)
• Korea University Medical Center (KR)
• St. Mary's Hospital (US)
• Gangnam Severance Hospital (KR)
• The Catholic University of Korea Seoul St. Mary's Hospital (KR)
• Korea University (JP)
• Catholic University of Korea (KR)

Publication Details

Journal

ESC Heart Failure

Published

2024-10-17

DOI

https://doi.org/10.1002/ehf2.15117

Citations

7

Primary Topic

Heart Failure Treatment and Management

Type

article

Field-Weighted Citation Impact

2.81

Funders

• Novartis Pharmaceuticals Corporation
• Korea Disease Control and Prevention Agency
• National Research Foundation
• Ministry of Science and ICT, South Korea
• Korea National Institute of Health